Related Experiment Video
Updated: Jun 15, 2025

12:41
Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
4.8K
Automatic Tumor Cellularity Measurement: AI-Based Pipeline for Multi-Organ Pathology Imaging
Suk Min Ha1, Young Sin Ko1,2, Youngjin Park1
1AI Research Center, Seegene Medical Foundation, Seoul, Korea.
Studies in Health Technology and Informatics
|August 23, 2024
Summary
AI accurately measures tumor cellularity (TC) in pathology images, overcoming challenges in cross-organ application and clustered cell counting. This automated approach enhances consistency and efficiency in assessing tumor burden.
Area of Science:
- Digital pathology
- Computational imaging
- Artificial intelligence in oncology
Background:
- Tumor cellularity (TC) is critical for evaluating organ tumor burden but manual counting is impractical due to image volume and inter-observer variability.
- Existing AI models struggle with applying pancreas-trained data to colon images and accurately segmenting clustered cells.
Purpose of the Study:
- To develop and validate an AI pipeline for accurate and automated tumor cellularity assessment in digital pathology images.
- To address the challenges of cross-organ generalization and clustered cell segmentation in AI-driven pathology.
Main Methods:
- A novel pipeline incorporating channel normalization for consistent RGB standardization across organs.
- Introduction of CacoX, a specialized cell segmentation model utilizing Coordinate Attention Gates and non-local learning for precise localization.
- Application of a watershed algorithm to automatically separate clustered cells in segmentation outputs.
Main Results:
- The proposed pipeline achieved 3rd place in the PAIP 2023 Challenge.
- An Interclass Correlation (ICC) score of 95.69% demonstrates high agreement and accuracy.
- The method effectively handled cross-organ data challenges and improved clustered cell separation.
Conclusions:
- The developed AI pipeline offers a robust solution for automated tumor cellularity measurement in digital pathology.
- This approach enhances consistency, efficiency, and accuracy compared to manual methods.
- The findings highlight the potential of specialized AI models and algorithms for advancing cancer burden assessment.

